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IL-4 Rapidly Produced by Vb4 Va8 CD41 T Cells
Instructs Th2 Development and Susceptibility
to Leishmania major in BALB/c Mice
Pascal Launois,* Ivan Maillard,§ Sabine Pingel,‖ (Scott et al., 1988; Holaday et al., 1991), substantial at-
tention has focused on the mechanism that mediatesKristin G. Swihart,* Ioannis XeÂ narios,²
differentiation of these disparate Th subsets in mice ofHans Acha-Orbea,²³ Heidi Diggelmann,§
different genetic backgrounds.Richard M. Locksley,‖ H. Robson MacDonald,³
The dominant role of cytokines in directing Th effectorand Jacques A. Louis*
cell differentiation has been most carefully studied in*World Health Organization
vitro using naive CD41 T cells from T cell receptor (TCR)Immunology Research and Training Center
ab transgenic mice. These experiments have implicated²Institute of Biochemistry
interleukin-12 (IL-12) in the differentiation of Th1 (Hsieh³Ludwig Institute for Cancer Research
et al., 1993) and IL-4 in the differentiation of Th2 effectorLausanne Branch
cells (Hsieh et al., 1992; Seder et al., 1992). Importantly,University of Lausanne
studies using neutralizing antibodies or mice with dis-Epalinges
ruption of the IL-12 or IL-4 genes on the appropriateSwitzerland
genetic backgrounds have defined critical roles for§ Institute of Microbiology
these cytokines in mediating both the differentiation ofUniversity of Lausanne
the appropriate Th subset (Kopf et al., 1993; Sypek etLausanne
al., 1993; Heinzel et al., 1995; Magram et al., 1996) andSwitzerland
the control or failure of control of L. major infection in‖Departments of Medicine and
vivo (Sadick et al., 1991; Sypek et al., 1993; Heinzel etMicrobiology/Immunology
al., 1995; Kopf et al., 1996; Mattner et al., 1996). BothUniversity of California
the in vitro and in vivo studies demonstrated that modu-San Francisco, California
lation of the outcome of Th differentiation and L. major
infection required that the respective cytokines be pres-
ent during the initial period of antigenic stimulation or
Summary infection with the parasites.
The requisite role of IL-4 in mediating both Th2 differ-
BALB/c mice develop aberrant T helper 2 (Th2) re- entiation and susceptibility to L. major has directed in-
sponses and suffer progressive disease after infection terest toward the source of the early IL-4 produced in
with Leishmania major. These outcomes depend on vivo. Prior studies from this laboratory have shown that
the production of interleukin-4 (IL-4) early after infec- susceptible BALB/c mice, in contrast to resistant
strains, exhibited a burst of IL-4 in CD41 T cells in thetion. Here we demonstrate that theburst of IL-4 mRNA,
draining lymph nodes within 16 hr after the subcutane-peaking in draining lymph nodes of BALB/c mice 16 hr
ous injection of L. major promastigotes (Launois et al.,after infection, occurs within CD41 T cells that express
1995). Importantly, this IL-4 production occurred duringVb4 Va8 T cell receptors. In contrast to control and
the period in which neutralizing anti-IL-4 antibody wasVb6-deficient BALB/c mice, Vb4-deficient BALB/c
capable of redirecting protective Th1 development inmice were resistant to infection, demonstrating the
BALB/c mice (Sadick et al., 1990; Chatelain et al., 1992)role of these cells in Th2 development. The early IL-4
and was not due to activation of NK1.11CD41 T cellsresponse was absent in these mice, and T helper 1
(Launois et al., 1995); the latter cells can contribute sub-responses occurred following infection. Recombinant
stantial amounts of early IL-4 production in vivo underLACK antigen from L. major induced comparable IL-4
certain conditions (Yoshimoto and Paul, 1994; Yoshi-production in Vb4 Va8 CD41 cells. Thus, the IL-4 re-
moto et al., 1995a, 1995b) but were not required for Th2quired for Th2 development and susceptibility to L.
development or progressive disease in BALB/c micemajor is produced by a restricted population of Vb4
infected with L. major (Brown et al., 1996; von der WeidVa8 CD41 T cells after cognate interaction with a single
et al., 1996). Based on these findings, we initiated stud-antigen from this complex organism.
ies to identify the population of CD41 T cells responsible
for the early production of IL-4 in response to L. major
Introduction and to define their role in mediating Th2 development
and disease susceptibility in BALB/c mice. Unexpect-
Mice from most inbred strains (e.g., C3H, CBA, and edly, these cells expressed a highly restricted TCR rep-
C57BL/6) are resistant to infection by Leishmania major, ertoire (Vb4 Va8), and comparable activation of these
an obligate intracellular parasite of macrophages in the cells could be demonstrated in vivo using recombinant
mammalian host. In contrast, mice from BALB strains LACK antigen from L. major.
are unable to control infection and develop progressive
disease (Reiner and Locksley, 1995). Resistance and Results
susceptibility have been correlated with the appear-
ance of parasite-specific T helper 1 (Th1) or T helper 2 TCR Vb and Va Use by CD41 T Cells That Express
(Th2) cells, respectively. Although passive transfer of IL-4 mRNA after Infection with L. major
L. major-specific Th1 or Th2 cells has alone conferred Intravenous injection of promastigotes of L. major into
susceptible BALB/c mice results in the appearance ofresistance or susceptibility to immunodeficient mice
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Figure 1. Analysis of TCR Vb Chain Use by CD41 T Cells That Express IL-4 mRNA Transcripts after Infection with L. major
CD41 T cells from spleens (A) of mice (five per group) injected intravenously with L. major 90 min previously or from popliteal lymph nodes
(C) of mice injected subcutaneously with L. major in the footpads 16 hr previously were separated from CD42 cells by MACS using magnetic
beads conjugated with anti-CD4 mAb GK 1.5. Purified CD41 T cells from spleens were stained with combinations of the designated anti-TCR
Vb chains antibodies (A) or with anti-Vb4 (KT4±10) or anti-Vb10 (B21.5) antibodies (B) and sorted into positive and negative Vb subpopulations
by flow cytometry. CD41 T cells purified from lymph nodes were similarly separated into Vb4-positive and Vb4-negative populations (C). RNA
was extracted from these separated cell populations and the relative levels of IL-4 mRNA were determined by semiquantitative RT-PCR as
described in Experimental Procedures. The results are expressed as the fold increase in IL-4 mRNA in mice infected with L. major as compared
to noninfected mice. These results are from one of two experiments with identical results.
IL-4 mRNA in the splenic CD41 T cell population that population of cells (Figure 2). A similar analysis demon-
strated that the IL-4 transcriptsat these early time pointspeaks after 90 min (Launois et al., 1995). To begin analy-
sis of the responding T cell populations, spleen cells in both spleen and lymph node cells were contained in
populations that expressed the activation markers CD69were prepared from mice that had been injected with
parasites 90 min previously, were enriched for CD41 (Figure 3A) or CD122 (IL-2Rb; Figure 3B). Taken to-
gether, these results localize the early IL-4 transcriptscells using magnetic bead selection, and were stained
with combinations of anti-TCR Vb-specific monoclonal initiated by infection with L. major to an activated popu-
lation of CD41 T cells that express Vb4 Va8 TCRs. Inantibodies (mAbs). After purification by flow cytometry,
total RNA was isolated from the designated Vb-positive contrast, analysis of CD41 T cell populations purified 5
days after subcutaneous infection during a second peakand -negative populations and analyzed for the pres-
ence of IL-4 mRNA using a competitive reverse tran-
scriptase polymerase chain reaction (RT-PCR) assay
(Reiner et al., 1993a). In agreement with prior observa-
tions (Launois et al., 1995), the increase in IL-4 tran-
scripts occurred only in CD41 T cells. Furthermore, the
increase in IL-4 mRNA was confined to CD41 T cells
that expressed Vb2, Vb4, or Vb10 (Figure 1A). Since
cells expressing Vb2 had been excluded during a prior
analysis of the potential contribution of NK1.11CD41 T
cells (Launois et al., 1995), further analysis was per-
formed using Vb4- or Vb10-positive cells purified from
the enriched CD41 population. By this analysis, all of
the IL-4 mRNA could be accounted for in CD41 T cells
that expressed the Vb4 TCR (Figure 1B). Similarly, the
burst of IL-4 mRNA expression peaking in draining
lymph node cells 16 hr after the subcutaneous inocula-
tion with parasites (Launois et al., 1995) also occurred
among CD41 T cells expressing the Vb4 TCR chain (Fig-
Figure 2. CD41 T Cells from Spleen (A) or Lymph Nodes (B) Thature 1C).
Express Rapidly IL-4 mRNA Transcripts in Response to InfectionPrevious observations have demonstrated that LACK-
with L. major Express the Va8 TCR Chain
reactive cells that expand early after infection of BALB/c
CD41 T cells were enriched by MACS from either the spleens (A) ofmice with L. major were heavily biased in use of the Vb4
mice (five per group) injected intravenously with L. major 90 min
Va8 heterodimeric TCR (Reiner et al., 1993b; Mougneau previously or the draining lymph nodes (B) of mice infected subcuta-
et al., 1995). To assess whether the early IL-4 mRNA neously in the footpads 16 hr previously. Purified CD41 T cells were
sorted with an anti-Va8 antibodies (KT 50.1) into Va8-positive andwas present in the CD41 T cellpopulation that expressed
Va8-negative subpopulations by fluorescence-activated cell sort-Va8, CD41 T cells were enriched from spleens of mice
ing. RNA was extracted from these separated cell populations andinjected intravenously with L. major 90 min previously
the relative levels of IL-4 mRNA were determined by semiquantita-or from the draining lymph nodes of mice injected sub-
tive RT-PCR as described in Experimental Procedures. The results
cutaneously in the footpad tissues with L. major 16 hr are expressed as the fold increase in IL-4 mRNA in mice infected
previously. Under both conditions, the early IL-4 tran- with L. major as compared to noninfected mice and are from one
of two experiments with similar results.scripts could be recovered in the Va8-positive CD41
Vb4 Va8 CD41 Cells and Susceptibility to L. major
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Figure 4. Early IL-4 mRNA Expression in Response to L. major Does
Not Occur in Draining Lymph Nodes of BALB/c Mice Deficient in
Vb4-Positive CD41 T Cells
Figure 3. Expression of CD69 and CD122 on the CD41 T Cells That BALB/c mice (three per group) deficient in either Vb4-positive or
Rapidly Express IL-4 mRNA Transcripts in Response to L. major Vb6-positive CD41 T cells as a result of neonatal exposure to
CD41 T cells from the spleen (A) or draining lymph nodes (B) were MMTV(SIM) or MMTV(SW), respectively, were killed 16 hr after sub-
enriched by MACS 90 min after intravenous or 16 hr after subcutane- cutaneous infection with L. major. RNA was extracted from their
ous infection, respectively, with L. major. After staining with either lymph nodes and the specific mRNA levels for IL-4 was determined
anti-CD69 (H1±2-F3) or anti-CD122 (TMb1) mAbs, purified CD41 T by semiquantitative RT-PCR. Results are expressed as the fold in-
cells were sorted in positive and negative subpopulations by fluores- crease in IL-4 mRNA as compared to noninfected mice. Results are
cence-activated cell sorting. RNA was extracted from these cells from one of three experiments that gave similar results.
and the relative levels of IL-4 mRNA weredetermined by semiquanti-
tative RT-PCR as described in Experimental Procedures. The results
are expressed as the fold increase in IL-4 mRNA in mice infected IL-4 transcripts. In contrast to control or MMTV(SW)-
with L. major as compared to noninfected mice and are from one infected mice, the Vb4-deficient mice previously in-
of two experiments with similar results. fected with MMTV(SIM) were unable to generate IL-4
transcripts in the CD41 T cell population under these
conditions (Figure 4). Analysis of additional time points
of IL-4 transcription and translation (Reiner et al., 1994; (data not shown) confirmed that this did not represent
Launois et al., 1995) demonstrated IL-4 expression an aberrant kinetic response to L. major, but rather a
among a broader range of CD41 T cells that was no markedly attenuated IL-4 response in the absence of
longer restricted only to those cells that utilized the Vb4 Vb4 CD41 T cells.
Va8 TCR (P. L. and J. A. L., unpublished data).
Abrogated Th2 Differentiation in Vb4 CD4±Deficient
BALB/c Mice Infected with L. majorVb4 CD4±Deficient BALB/c Mice Do Not Exhibit
Early IL-4 mRNA Expression after Inoculation BALB/c mice develop an aberrant polarized Th2 re-
sponse after infection with L. major that underlies thewith L. major
The 39 long terminal repeats of the mouse mammary susceptibility of these animals (Reiner and Locksley,
1995). Immunologic manipulations that redirect the im-tumor viruses MMTV(SIM) and MMTV(SW) encode a su-
perantigen that leads initially to local stimulation and mune response to curative Th1 responses share the
property of attenuating the amounts of IL-4 producedsubsequently to systemic deletion of CD41 T cells ex-
pressing Vb4 or Vb6 TCR, respectively (Held et al., 1992; at the time of infection, consistent with the critical role
for this cytokine in mediating Th2 differentiation. Aboli-Maillard et al., 1996). Cohorts of newborn BALB/c
pups were nursed on BALB/c mothers infected with tion of the very early IL-4 mRNA produced in response
to L. major in MMTV(SIM)-infected BALB/c mice allowedMMTV(SIM) or MMTV(SW). Excretion of the viruses in
the milk by the infected mothers causes infection of the us to correlate the presence or absence of early IL-4
transcripts in Vb4 CD41 T cells, with the ultimate devel-pups, resulting in progressive deletion of the respective
CD41 T cell populations in the newborn mice. Twenty opment of a polarized Th2 response weeks later.
Groups of BALB/c mice either left uninfected or pre-weeks after birth, the percentage of CD41 T cells that
expressed Vb4 or Vb6 was determined using flow cy- viously infected with MMTV(SIM) or MMTV(SW) and ren-
dered Vb4 or Vb6 CD4±deficient, respectively, togethertometry afterstaining peripheral blood lymphocytes with
the appropriate mAbs. The percentages of Vb4 and Vb6 with resistant C57BL/6 mice, were inoculated in the hind
footpads with L. major promastigotes. After 4 weeks,CD41 T cells were, respectively, 0.7% 6 0.3% (mean 6
SD) and 11.2% 6 0.5% in mice infected with MMTV(SIM) by which time polarized Th differentiation can be dem-
onstrated, mice were killed and cells from the drainingand 8.5% 6 0.7% and 0.7% 6 0.2% in mice infected
with MMTV(SW). Age-matched uninfected BALB/c mice lymph nodes were harvested for cytokine mRNA and
protein assays. As compared to uninfected controlhad 7.6% 6 0.5% Vb4 CD41 and 10.8% 6 0.5% Vb6
CD41 T cells. BALB/c mice, BALB/c mice infected with L. major had
125-fold increases in the amounts of IL-4 transcriptsCohorts of MMTV(SIM)-infected, MMTV(SW)-infected,
and uninfected, age-matched, BALB/c (20- to 45-week- and 30-fold increases in the amounts of interferon-g
(IFNg) transcripts (Figure 5). Infected C57BL/6 mice de-old) mice were infected in the subcutaneous footpad
tissues with L. major and the draining lymph nodes cells veloped a typical Th1 response, with high levels of IFNg
transcripts and very low levels of IL-4. Remarkably,harvested after 16 hr for analysis of total mRNA for
Immunity
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Figure 5. Cytokine Transcripts in Lymph Node Cells 28 Days after
Infection with L. major
Cells were isolated from popliteal lymph nodes of infected BALB/c,
C57BL/6, and BALB/c mice deficient either in Vb4-positive or in
Vb6-positive CD41 T cells. RNA was extracted and the levels of
IFNg mRNA and IL-4 mRNA were determined by semiquantitative
RT-PCR. Results are expressed as the fold increase in IL-4 or in
IFNg mRNA as compared to noninfected mice. Similar results were Figure 6. Course of L. major Infection in BALB/c Mice Deficient in
obtained in two separate experiments. Vb4-Positive CD41T Cells
BALB/c, C57BL/6, and BALB/c mice deficient in either Vb4-positive
or Vb6-positive CD41 T cells (four per group) were inoculated in one
BALB/c mice rendered Vb4-deficient by prior infection hind footpad with 3 3 106 stationary phase L. major promastigotes.
The size of the footpad lesion was monitored using a vernier caliperwith MMTV(SIM) developed a Th1 response in the CD41
as described in Materials and Methods. The mean sizes of lesionsT cell population that closely resembled that present in
and SD are shown. Similar results were obtained in another separatethe genetically resistant C57BL/6 mice. This effect was
experiment.
due to the specific deletion of Vb4-positive cells, since
deletion of comparable numbers of total CD41 T cells
by infection with MMTV(SW) did not affect Th2 develop- Vb4 CD4±deficient, but not Vb6 CD4±deficient, BALB/c
mice controlled the extent of disease in a manner notment in L. major±infected BALB/c mice. Comparable
results were obtained when the designated purified substantially different from concurrently infected C57BL/6
mice (Figure 6). Furthermore, the numbers of viable par-lymph node cell populations were incubated with ultravi-
olet-irradiated L. major for 72 hr and the supernatants asites recovered after culture in vitro of footpad tissues,
removed 4 weeks after infection, confirmed that parasitewere analyzed for the accumulation of IL-4 and IFNg
(Table 1). The Vb4-deficient BALB/c mice infected with growth was controlled in Vb4 CD4±deficient mice (1.3 3
105 L. major/footpad lesion) comparably to that in theMMTV(SIM), but not control or MMTV(SW)-infected
BALB/c mice, developed strong Th1-like cytokine pro- resistant strain (0.5 3 105), and both groups contained
significantly fewer parasites than control BALB/c micefiles that were comparable to those that occurred spon-
taneously in C57BL/6 mice infected concurrently. Thus, (1 3 107) or Vb6 CD4±deficient BALB/c mice (1.3 3 107).
Taken together, these results demonstrate that Vb4as assessed by analysis of both mRNA and protein pro-
duction, Th2 responses in BALB/c mice infected with Va8 CD41 T cells were the source of the early IL-4 tran-
scripts produced after infection of BALB/c mice with L.L. major could be abrogated by deletion of Vb4 CD41
T cells. major and that the presence of these cells was required
for subsequent Th2 development and the establishment
of progressive disease.Resistance to L. major Infection in Vb4
CD4±Deficient BALB/c Mice
The capacity of MMTV(SIM)-mediated Vb4 deletion to Recombinant LACK Protein from L. major
Induces Early IL-4 mRNA in BALB/c Miceabrogate Th2 development in BALB/c mice infected with
L. major suggested that these mice might be rendered Prior studies demonstrated that biased expansion of
CD41 T cells that expressed the Vb4 Va8 TCR occurredresistant to progressive disease. Indeed, as assessed
by measurements of the footpad lesion sizes over time, in the lymph node cell population draining the site of
Table 1. IL-4 and IFNg Production In Vitro by Specifically Stimulated Lymph Node Cells Obtained from BALB/c Mice Deficient in
Vb4-Positive T Cells 4 Weeks after Infection with L. major
IFNg (IU/ml) IL-4 (pg/ml)
Mice Ð L. major Ð L. major
BALB/c deficient in Vb4 CD41 T cells 823 11,764 ND 40
BALB/c deficient in Vb6 CD41 T cells 631 5,882 765 7142
BALB/c 631 7,058 742 7142
C57BL/6 83 7,058 ND 100
IL-4 and IFNg production by cells cultured with or without ultraviolet-irradiated parasites were measured by biossay and enzyme-linked
immunosorbent assay, respectively, as described in Experimental Procedures.
ND, not detectable.
Vb4 Va8 CD41 Cells and Susceptibility to L. major
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Figure 7. In BALB/c Mice the LACK Protein
from L. major Rapidly Induces IL-4 mRNA Ex-
pression in Draining Lymph Node CD41 T
Cells That Express the Vb4 Va8 TCR
(A) The LACK protein induces IL-4 mRNA ex-
pession in lymph nodes cells of BALB/c mice.
BALB/c (open squares) and C57BL/6 mice
(closed squares) (three per group) were killed
at various times after the subcutaneous injec-
tion into the hind footpads of recombinant
LACK protein (pET3a-d9-rLACK, 5 mg). In ad-
dition BALB/c mice from a separate group
received the recombinant LACK deleted pro-
tein (pET3a-d9-rLACK(D41), 5 mg [open trian-
gles] or 25 mg [closed triangles]). RNA was
extracted from their lymph nodes and the lev-
els of IL-4 mRNA was determined by semiquantitative RT-PCR. Results are expressed as the fold increase in IL-4 mRNA as compared to
noninfected mice.
(B) The CD41 cells from BALB/c lymph nodes that expressed IL-4 mRNA transcripts in response to LACK express the Vb4 Va8 TCR. CD41
T cells from the draining lymph nodes of BALB/c mice injected with 5 mg of LACK (pET3a-d9-rLACK) 16 hr previously were eniched by MACS.
After staining with either anti-Va8 (KT 50±1) or with an anti-Vb4 (KT4±10) antibodies purified CD41 T cells were sorted by flow cytometry into
positive and negative Va8 or Vb4 subpopulations, respectively. RNA was extracted from these cells and the relative levels of IL-4 mRNA were
determined by semiquantitative RT-PCR as described in Experimental Procedures. The results are expressed as the fold increase in IL-4
mRNA in mice infected with L. major as compared to noninfected mice. Similar results were obtained in two individual experiments.
inoculation with L. major in BALB/c mice (Reiner et al., Finally, MMTV(SIM)-infected BALB/c mice that were
Vb4 deficient generated no early IL-4 transcripts in the1993b). These cells were shown subsequently to recog-
nize the Leishmania homolog of mammalian RACK1, draining lymph nodes in response to subcutaneous in-
jection of LACK, in contrast to MMTV(SW)-infected micedesignated LACK (Mougneau et al., 1995), a member of
an ancient family of highly conserved proteins that share with normal numbers of Vb4 CD41 T cells (Figure 8).
Neither group of mice generated an early IL-4 responserepetitive GH-WD structural domains (Neer et al., 1994).
Analysis of a number of T cell hybridomas established to the LACK deletion protein. Thus, Vb4 Va8 CD41 T
cells are required for the early IL-4 response to bothfrom BALB/c mice immunized with recombinant LACK
revealed a single dominant I-Ad±restricted T cell epitope LACK and Leishmania promastigotes.
in the fourth WD domain of LACK, comprising amino
acid residues 156±173 (R. M. L., unpublished data). Discussion
The coincident use of Vb4 Va8 TCR expression among
CD41 cells that recognized LACK and cells that con- These data establish that a highly restricted subpopula-
tion of CD41 T cells that expressed the Vb4 Va8 TCRtained the early IL-4 transcripts in response to infection
with L. major suggested that these cells might be re- was responsible for the early burst of IL-4 transcription
that occurred in BALB/c mice following intravenous orsponding in a cognate fashion to the LACK epitope. To
establish whether the LACK antigen could induce IL-4 subcutaneous injection of L. major (Launois et al., 1995).
BALB/c mice rendered deficient in Vb4 CD41 T cellstranscripts in a kinetically similar fashion, BALB/c mice
were injected in the footpads with 5 mg of recombinant were incapable of generating this early IL-4 transcrip-
tional burst, and, importantly, were unable to generateLACK protein, and the lymph node cells were collected
at designated periods for analysis of IL-4 mRNA expres- the typical Th2 immune response that occurs in these
mice in response to L. major infection. In the absencesion using RT-PCR. Transcripts for IL-4 were readily
detected by this analysis, with a peak at 16 hr that only of early IL-4 production, Th development defaulted to
the Th1 pathway, allowing these animals to establishslowly decayed over the ensuing 10 days (Figure 7A).
This IL-4 mRNA was not seen after injection of C57BL/6 protective immunity to this otherwise lethal infection.
Further, recombinant LACK antigen from L. major, pre-mice with the LACK antigen using the same conditions
(Figure 7A). The induction of IL-4 mRNA was dose de- viously identified as a target of the early CD41 T cell
response in mice (Mougneau et al., 1995), was capablependent, and when tested in parallel the fold increase
in transcript abundance induced by 5 mg of the recombi- of inducing IL-4 transcripts in Vb4 Va8 CD41 T cells at
similar early time points after subcutaneous injectionnant protein was comparable to that induced by 3 3
106 stationary-phase promastigotes (data not shown). into BALB/c mice. Induction of IL-4 mRNA by LACK was
abrogated by deletion of the dominant T cell epitopeTo confirm that the expression was dependent on the
LACK I-Ad T cell epitope, a recombinant LACK deletion from the antigen or by injection into Vb4 CD4±deficient
mice. Taken together with other data implicating recog-protein missing 41 amino acids that included the 18±
amino acid epitope was expressed and purified from nition of the LACK antigen in mediating the phenotype
of BALB/c mice infected with L. major (Julia et al., 1996),the same vector. When injected into BALB/c mice, the
LACK deletion construct induced no IL-4 mRNA as com- these experiments suggest that cognate recognition of
a single epitope in the LACK antigen drives the earlypared to the intact protein, even when injected in 5-fold
greater amounts (Figure 7A). CD4 enrichment and flow IL-4 response by a restricted population of major histo-
compatibility (MHC) class II±restricted CD41 T cells re-cytometric purification of Vb4-positive and Va8-positive
cells confirmed that the IL-4 induced by the LACK anti- sponsible for the aberrant Th2 differentiation that occurs
with progressive disease. These data have importantgen occurred in Vb4 Va8 CD41 T cells (Figure 7B).
Immunity
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Figure 8. LACK Does Not Induce IL-4 mRNA
Expression in Lymph Nodes of BALB/c Mice
Deficient in Vb4 CD41 Cells
Draining lymph node cells from the desig-
nated mice were collected 16 hr after the sub-
cutaneous injection of 5 mg of recombinant
LACK (pET3a-d9-rLACK) and RNA used to
prepare cDNA by reverse transcription. Semi-
quantitative PCR was performed following
the conditions published by Reiner et al.
(1993a). Photographs of ethidium bromide
stained gels of representative PCR reactions
using HPRT and IL-4±specific primers in the
presence of serial 5-fold dilutions of competitor are shown. The concentrations of competitor used were as follows, HPRT: 250±0.4 pg/ml;
IL-4: 10±0.08 pg/ml. In all cases the upper band is due to amplification of the competitor construct that contains a larger PCR product and
the lower band is due to amplification of the cDNA. The point of equivalence between the competitor and the cDNA indicates the relative
concentration of mRNA. The relative concentration of HPRT was used to control for differences in mRNA concentration and efficiency of
cDNA synthesis.
implications for the understanding of susceptibility to L. major. The realization that CD41 T cells themselves
infectious pathogens and suggest novel strategies that provide the IL-4 required for Th2 development is consis-
might be used in otherwise susceptible hosts. tent with passive transfer experiments that demon-
Although a critical role for IL-4 in directing Th2 differ- strated the capacity of highly purified CD41 T cells to
entiation in vivo has been demonstrated in several sys- reconstitute IgE antibody production in immunized IL-
tems (Le Gros et al., 1990; Kopf et al., 1993; Kopf et al., 4±deficient mice (Schmitz et al., 1994).
1996), considerable uncertainty surrounds the source The identification of Vb4 Va8 CD41 T cells as the
of the early IL-4 produced. Roles for gd T cells (Ferrick source of early IL-4 production after16 hrwas consistent
et al., 1995), NK1.11CD41 T cells (Yoshimoto and Paul, with experiments demonstrating expansion of cells with
1994; Yoshimoto et al., 1995a, 1995b), eosinophils (Sa- the same TCR in the draining lymph nodes 10±14 days
bin and Pearce, 1995) and cells of the mast cell/basophil after infection (Reiner et al., 1993b). The parasite antigen
lineage (Paul et al., 1993) have been suggested invarious recognized by these cells, designated LACK, was sub-
experimental models. The murine model of infection with sequently cloned (Mougneau et al., 1995), allowing us
L. major is a well-characterized MHC class II±dependent to test whether the antigen itself could activate a similar
infectious disease in which the early production of IL-4 population of cells in vivo. Remarkably, the recombinant
has been repeatedly implicated in mediating Th2 differ- antigen induced IL-4 mRNA after 16 hr in the same re-
entiation and progressive infection (Reiner and Lock- stricted population of Vb4 Va8 CD41 T cells in BALB/c,
sley, 1995). Recent data have even pinpointed a narrow but not C57BL/6, mice; the recognition was confined
window of time, of less than 48 hr after infection, during to a single epitope; and activation was absent in mice
which the IL-4 rapidly produced in BALB/c mice irrevers- rendered Vb4 deficient by prior infection with MMTV
ibly drives the differentiation of CD41 T cells toward (SIM). Importantly, these experiments that demonstrate
the Th2 phenotype (Launois et al., 1997). Significant IL-4 mRNA induction by the LACK antigen but not by
requirements for any of these other cell types has never the epitope deletion mutant support the argument that
been convincinglydemonstrated in this model. In partic- no other adjuvant-like molecules provided by the organ-
ular, the NK1.11CD41 population that has been impli- ism are required to induce IL-4 by CD41 T cells in the
cated in producing essentially all of the early IL-4 after
genetically susceptible host. Although the data remain
injection of anti-CD3 (Yoshimoto and Paul, 1994) or anti±
correlative, the experiments suggest the hypothesis that
immunoglobulin D (anti-IgD) (Yoshimoto et al., 1995a)
a single determinant in the parasite LACK antigen under-antibodies into mice was excluded by direct analysis of
lies Th2 development in susceptible BALB/c miceVb chain use in this and an earlier (Launois et al., 1995)
through a cognate interaction with I-Ad±restricted CD41study that were unable to demonstrate early IL-4 tran-
T cells. A similar conclusion was suggested by experi-script accumulation in the Vb8, Vb7, and Vb2 CD41 T
ments in which LACK was expressed in the thymuscells that constitute the NK1.11 subset (Lantz and Ben-
under MHC class II promoters in transgenic BALB/cdelac, 1994). Furthermore, b2-microglobulin-deficient
mice, thus rendering animals tolerant to LACK (Juliamice on the BALB/c background, which are deficient in
et al., 1996). These mice, like the Vb4-deficient miceNK1.11CD41 T cells that are selected on the b2-micro-
examined here, were resistant to L. major, and resis-globulin-dependent CD1 molecule (Bendelac, 1995;
tance was associated with the development of pro-Brutkiewicz et al., 1995), demonstrated normal Th2 dif-
tective Th1 immunity. Although expression of theferentiation and disease progression after infection with
transgenic LACK I-Ad epitope in the thymus might beL. major (Brown et al., 1996; von der Weid et al., 1996).
argued to affect the T cell repertoire in mechanismsThe data indicating absolute requirements for MHC
independent of LACK reactivity, we obtained the sameclass II (Locksley et al., 1993) and, as shown here, Vb4
results in the MMTV(SIM)-infected mice that deletedVa8 CD41 T cells, in Th2 development, suggest that a
only Vb4 CD41 T cells. This effect is unlikely to reflectsmall population of classical ab CD41 T cells is neces-
sary for effector lineage commitment in response to nonspecific effects of virus infection or partial T cell
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depletion, since mice infected with MMTV(SW) that de- aberrant Th immune response engendered by this or-
ganism. A larger L. major±specific CD41 precursor fre-pleted comparable numbers of CD41 T cells that ex-
quency has been documented in naive BALB/c, as com-pressed Vb6 were not protected from L. major.
pared to resistant, mice (Milon et al., 1986; Morris etAlthough it is possible that LACK may constitute a
al., 1992), but the antigenic specificity of the parasite-ªTh2 epitope,º we think this unlikely based on several
reactive precursors remains unknown. Confirmation ofobservations. First, injection of the recombinant antigen
this hypothesis would imply that the genetic susceptibil-into resistant C57BL/6 mice results in small but detect-
ity to L. major requires not only a polymorphism in Thable amounts of IFNg mRNA at 16 hr, indicating that
subset development (Hsieh et al., 1995; Gorham et al.,recognition of this antigen is not invariably associated
1996) but also the proper thymic environment for thewith IL-4 production. Second, immunization with LACK
selection of sufficient numbers of Vb4 Va8 CD41 LACK-and IL-12 can redirect the dominant Th2 response and
specific T cells to direct Th2 lineage commitment ofprotect subsequently infected BALB/c mice, indicating
subsequently activated CD 41 T cells. Convergence ofthat Th1 effector development can occur with LACK-
both of these genotypes would be required to mediatereactive cells (Mougneau et al., 1995). Last, we have
susceptibility to this organism. The fine specificity of thiscreated TCR transgenic mice with cells that recognize
critical subset of CD41 T cells suggests that methodsthe LACK I-Ad epitope and can demonstrate no inherent
for antigen-specific targeting that attempt to delete orTh2 bias using transgenic T cells from B10.D2 mice
tolerize such cells would constitute novel interventionalwhen cells are primed in vitro with the LACK peptide
strategies for the prevention of serious infectious dis-(S. L. Reiner et al., unpublished data).
eases.What then might underlie susceptibility to L. major in
BALB strain mice? Others have documented the genetic
Experimental Procedurestendency of naive CD41 T cells from BALB/c mice to
generate responses biased toward the increased pro-
Mice
duction of IL-4 after priming in the absence of exoge- Female BALB/c mice were purchased from IFFA Credo (St. Germain
nous cytokines under otherwise neutral conditions sur l'Abresle, France) or from Harlan Olac Ltd. (Bicester, U. K.) and
(Hsieh et al., 1995). This preferential Th2 cell develop- used at 6±8 weeks of age. In experiments using MMTV(SIM)- and
MMTV(SW)-infected mice, control and infected mice were at leastment has been proposed to result from a loss of respon-
20 weeks old.siveness to IL-12 by BALB/c T cells after stimulation
with antigen in vitro (GuÈ ler et al., 1996). The small amount
Parasitesof IL-4 produced during the primary stimulation of
L. major LV 39 (MRHO/Sv/59/P-strain) were maintained in vivo and
BALB/c naive CD41 T cells is nonetheless functionally grown in vitro as described (Louis et al., 1979). For infection, mice
critical, in that neutralization using anti-IL-4 mAbs re- were inoculated with 3 3 106 stationary-phase promastigotes either
sulted in striking redirection of the resulting effector intravenously or subcutaneously into one hind footpad. The footpad
lesions were measured weekly with a vernier caliper and comparedcells to the Th1 phenotype (Hsieh et al., 1992). In this
to the thickness of the uninfected footpad. In designated experi-context, we have recently shown that 48 hr after infec-
ments, footpad tissues were used to create limiting dilutions fortion with L. major, CD41 T cells from draining lymph
quantitation of viable parasite burdens as previously described (Ti-
nodes of BALB/c mice become unresponsive to IL-12 tus et al., 1985).
in vitro and that this IL-12 unresponsiveness is totally
prevented by neutralization of the IL-4 produced in vivo Antibodies
The following mAbs were used in these studies: B20.6.5 (anti-Vb2);during the first days of infection (Launois et al., 1997).
KJ25 (anti-Vb3); KT4±10 (anti-Vb4); MR9±4 (anti-Vb5); 44±22.1 (anti-Since our previous results have shown that IL-12 and
Vb6); TR310 (anti-Vb7); F23.1 (anti-Vb8.1, 8.2, 8.3); MR10±2 (anti-IFNg given to BALB/c mice before infection completely
Vb9); B21.5 (anti-Vb10); MR12.4 (anti-Vb13); 14.2 (anti-Vb14); KT50.1
suppress the early IL-4 response (Launois et al., 1995) (anti-Va8); phycoerythrin-conjugated TMb1 (anti-IL-2Rb; Pharmingen,
shown here to occur among Vb4 Va8 CD41 T cells, the San Diego, CA); fluorescein isothiocyanate (FITC)±conjugated H1±2-
possibility exists that this response is down-regulated F3 (anti-CD69). FITC-conjugated goat anti-rat (CalTag Laboratories,
San Francisco, CA) or anti-mouse (Becton Dickinson, Mountainin resistant mice by these cytokines produced either
View, CA) IgG1 or IgG2 antisera were used to stain cells incubatedendogenously or rapidly following infection. In this con-
with anti-TCR Vb- or Va-specific hybridoma supernatants.
text, although IL-12 p40 production has been shown in
BALB/c mice early after infection, inhibition of its func- Fluorescent Cell Sorting
tion by other cytokines produced simultaneously has CD41 Tcells were purified from either the spleen ordraining popliteal
been reported (Scharton-Kersten et al., 1995). It is also lymph nodes using Magnetic Activated Cell Sorting (MACS, Miltenyi
Biotec, Bergishgladbach, Germany) according the manufacturer'spossible that the Vb4 Va8 CD41 T cell population repre-
directions. In brief, cells were suspended with magnetic microbeadssents a unique lineage in BALB/c mice that releases
that had been conjugated with anti-CD4 mAb (GK1.5) and isolatedeven greater amounts of IL-4 under conditions of neutral
after immobilization with a magnet. This procedure resulted in popu-
priming. More likely, however, is that a greater LACK- lations consisting of 85% CD41 T cells as determined by flow cyto-
specific T cell precursor frequency in BALB mice could metric analysis using phycoerythrin-conjugated anti-CD4 mAb. The
enriched CD41 populations were stained with designated Vb- oraccount for the capacity of the initial IL-4 production in
Va-specific hybridoma supernatants followed by the appropriateresponse to the LACK epitope to exceed the threshold
FITC-conjugated anti-rat or anti-mouse immunoglobulin antisera.required for Th2 lineage commitment. Given the inherent
Cells were sorted into positive and negative populations using a
genetic tendency to overproduce IL-4 by naive CD41 T FACStar Plus Flow Cytometer (Becton Dickinson). The purity of the
cells from these mice, activation of a larger pool of cells sorted cell populations that expressed the corresponding marker
was 99%.at the time of initiation of infection could underlie the
Immunity
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RNA Extraction and Competitive PCR Analysis media (Dulbecco's modified Eagle's medium containing 5% heat-
Total RNA was isolated from sorted negative and positive CD41 T inactivated fetal calf serum, 216 mg/ml L-glutamine, 5 3 10±5 M
cell populations as previously described (Launois et al., 1995). First- 2-mercaptoethanol, and 10 mM HEPES) in a 7% CO2 atmosphere
strand cDNA synthesis was performed using a kit according to the at 378C. After 72 hr, supernatants were collected and stored at
manufacturer's directions (Pharmacia, Uppsala, Sweden). The cyto- 2208C until analysis. IFNg was measured in supernatants by ELISA
kine polycompetitor plasmid pQRS was used to quantitate amounts as described (Slade and Langhorne, 1989). Mouse rIFNg (superna-
of transcripts for IFNg, IL-4, and the constitutively expressed gene, tant from L1210 cells transfected with the murine IFNg gene; a kind
hypoxanthine guanine phosphoribosyltransferase (HPRT), using the gift of Y. Wanabene, Kyoto University, Kyoto, Japan) was used as
primers and PCR conditions described (Reiner et al., 1993a). The a standard. IL-4 was measured by bioassay using the CTLL-44 cell
first-strand cDNA was used as a template in the presence of 5-fold line (a kind gift of P. Erb, University of Basel, Switzerland) as pre-
serial dilutions of plasmid pQRS. After separation of the amplified viously described (Favre and Erb, 1993). Mouse rIL-4 expressed
PCR products by electrophoresis in agarose-containing ethidium in X63Ag-653 cells (a kind gift of F. Melchers, Basel Institute of
bromide, the ratiosof the relative amounts of IFNg or IL-4 transcripts Immunology, Basel, Switzerland) was used as a standard. The limits
to the relative amounts of HPRT were calculated. The results are of detection in these assays were 10 U/ml for IFNg and 20 pg/ml
expressed as the fold increase in mRNA expression in mice infected for IL-4.
with L. major as compared to uninfected mice.
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